<code id='4897BD64E0'></code><style id='4897BD64E0'></style>
    • <acronym id='4897BD64E0'></acronym>
      <center id='4897BD64E0'><center id='4897BD64E0'><tfoot id='4897BD64E0'></tfoot></center><abbr id='4897BD64E0'><dir id='4897BD64E0'><tfoot id='4897BD64E0'></tfoot><noframes id='4897BD64E0'>

    • <optgroup id='4897BD64E0'><strike id='4897BD64E0'><sup id='4897BD64E0'></sup></strike><code id='4897BD64E0'></code></optgroup>
        1. <b id='4897BD64E0'><label id='4897BD64E0'><select id='4897BD64E0'><dt id='4897BD64E0'><span id='4897BD64E0'></span></dt></select></label></b><u id='4897BD64E0'></u>
          <i id='4897BD64E0'><strike id='4897BD64E0'><tt id='4897BD64E0'><pre id='4897BD64E0'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:972

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

          advertisement

          Sponsor Introduction

          • Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

          Featured Speakers

          • Angus Chen, cancer reporter, STAT
          • Adam Feuerstein, senior writer, biotech, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Katherine MacPhail, programmer, editorial events, STAT (moderator)

          Sponsored By

          focus

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex
          Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

          IsnoonesafefromtheFTC?HasPfizerbottomedout?Andisbiotechfinallyback?Wecoverallthatandmorethisweekon“T

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          3 questions for the future of Biden's cancer moonshot

          PresidentJoeBidenEliseAmendola/APWASHINGTON—ThelatestphaseofPresidentBiden’sCancerMoonshotinitiative